Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-22

Clinical Trial Update: The Safety of Intravenous Lacosamide [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing the safety of intravenous lacosamide in epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

Sponsor: Le Bonheur Children's Hospital | Conditions: Epilepsy | Phase 4 | Status: COMPLETED